News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
349,428 Results
Type
Article (21680)
Company Profile (151)
Press Release (327597)
Section
Business (109599)
Career Advice (893)
Deals (19045)
Drug Delivery (95)
Drug Development (53525)
Employer Resources (84)
FDA (8116)
Job Trends (8188)
News (193763)
Policy (18217)
Tag
Academia (924)
Alliances (29184)
Alzheimer's disease (664)
Approvals (8100)
Artificial intelligence (90)
Bankruptcy (171)
Best Places to Work (6010)
Biosimilars (71)
Biotechnology (73)
Breast cancer (84)
Cancer (751)
Cardiovascular disease (71)
Career advice (726)
Cell therapy (129)
Clinical research (44123)
Collaboration (293)
Compensation (96)
COVID-19 (1185)
C-suite (71)
Data (837)
Diabetes (124)
Diagnostics (1896)
Drug pricing (97)
Earnings (39366)
Employer resources (77)
Events (51365)
Executive appointments (265)
FDA (8478)
Funding (214)
Gene therapy (107)
GLP-1 (515)
Government (1998)
Healthcare (6847)
Infectious disease (1241)
Inflammatory bowel disease (78)
Interviews (120)
IPO (7660)
Job creations (2466)
Job search strategy (662)
Layoffs (260)
Legal (4210)
Lung cancer (114)
Lymphoma (71)
Manufacturing (152)
Medical device (2194)
Medtech (2197)
Mergers & acquisitions (11480)
Metabolic disorders (391)
Neuroscience (877)
NextGen Class of 2024 (2723)
Non-profit (2003)
Northern California (840)
Obesity (241)
Opinion (185)
Patents (87)
People (34387)
Pharmaceutical (79)
Phase I (13800)
Phase II (18768)
Phase III (14997)
Pipeline (328)
Policy (73)
Postmarket research (1696)
Preclinical (4959)
Radiopharmaceuticals (156)
Rare diseases (194)
Real estate (3261)
Regulatory (12875)
Research institute (1167)
Resumes & cover letters (141)
Southern California (762)
Startups (2120)
United States (7539)
Vaccines (236)
Weight loss (199)
Date
Today (59)
Last 7 days (339)
Last 30 days (1287)
Last 365 days (19043)
2024 (18974)
2023 (21131)
2022 (27728)
2021 (28769)
2020 (26866)
2019 (22017)
2018 (17052)
2017 (18245)
2016 (17365)
2015 (20052)
2014 (15632)
2013 (13204)
2012 (14020)
2011 (14407)
2010 (13252)
Location
Africa (437)
Asia (25340)
Australia (3357)
California (1886)
Canada (870)
China (193)
Colorado (76)
Connecticut (73)
Europe (52803)
Florida (270)
Illinois (182)
Indiana (128)
Maryland (302)
Massachusetts (1553)
Minnesota (108)
New Jersey (710)
New York (544)
North Carolina (437)
Northern California (840)
Ohio (75)
Pennsylvania (435)
South America (627)
Southern California (762)
Texas (260)
Washington State (167)
349,428 Results for "cure pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Code Pharma’s Gammora® Demonstrates Highly Favorable Outcomes Toward a Potential Cure for HIV
November 13, 2024
·
2 min read
Pharm Country
Mitsubishi Tanabe Pharma America Presents New Results of RADICAVA® (edaravone) for People Living with ALS at the European Network to Cure ALS (ENCALS) Meeting 2024
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced results from two studies of RADICAVA® (edaravone) for amyotrophic lateral sclerosis (ALS) at the European Network to Cure Amyotrophic Lateral Sclerosis (ENCALS) 2024 meeting.
June 17, 2024
·
8 min read
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Deals
Two Private Equity Firms Near Potential $3B+ Deal for Mitsubishi’s Pharma Unit: Reuters
Blackstone and Bain Capital are said to be among the final bidders for the Japanese company’s Mitsubishi Tanabe Pharma, sources told Reuters Friday.
December 13, 2024
·
1 min read
·
Annalee Armstrong
Business
The Biggest Pharma Share Moves of the Year So Far
Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share price. Other companies have not been so lucky.
November 27, 2024
·
9 min read
·
Annalee Armstrong
Press Releases
Cure Rare Disease Appoints Brittany Stineman as Chief Advancement Officer
December 18, 2024
·
2 min read
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Rare diseases
Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D
A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still extremely low compared to the money flowing to more common indications.
November 20, 2024
·
7 min read
·
Heather McKenzie
Business
Cure Rare Disease Expands Leadership Team and Board of Directors to Advance Mission
Cure Rare Disease, a clinical-stage nonprofit biotechnology organization, announces the addition of a Chief Advancement Officer to its leadership team and welcomes three new members to its board of directors.
June 17, 2024
·
3 min read
Press Releases
8 Years Survival with Complete Cure for a Patient with Advanced Liver Cancer Being Treated with Can-Fite’s Namodenoson Drug
December 5, 2024
·
6 min read
1 of 34,943
Next
